Literature DB >> 27308085

Papilledema Due to Mirtazapine.

Mehmet Emin Ceylan1, Alper Evrensel1, Gökçe Cömert1.   

Abstract

BACKGROUND: Mirtazapine is a tetracyclic antidepressant that enhances both noradrenergic and serotonergic transmission. The most common cause of papilledema is increased intracranial pressure due to brain tumor. Also it may occur as a result of idiopathic intracranial hypertension (IIH, pseudo tumor cerebri). Moreover, papilledema may also develop due to retinitis, vasculitis, Graves' disease, hypertension, leukemia, lymphoma, diabetes mellitus and radiation. CASE REPORT: In this article, a patient who developed papilledema while under treatment with mirtazapine (30 mg/day) for two years and recovered with termination of mirtazapine treatment was discussed to draw the attention of clinicians to this side effect of mirtazapine.
CONCLUSION: Idiopathic intracranial hypertension and papilledema due to psychotropic drugs has been reported in the literature. Mirtazapine may rarely cause peripheral edema. However, papilledema due to mirtazapine has not been previously reported. Although papilledema is a very rare side effect of an antidepressant treatment, fundoscopic examinations of patients must be performed regularly.

Entities:  

Keywords:  Antidepressant; mirtazapine; papilledema; side effect

Year:  2016        PMID: 27308085      PMCID: PMC4899000          DOI: 10.5152/balkanmedj.2016.150151

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  6 in total

1.  An unexpected case of swollen optic nerves.

Authors:  Marcia L Hutcheon
Journal:  Am J Ther       Date:  2011-07       Impact factor: 2.688

2.  Pseudotumor cerebri in a patient being treated for bipolar disorder.

Authors:  Yeşim Yetimalar Beckmann; Yaprak Seçil; Buket Belkiz Güngör
Journal:  Gen Hosp Psychiatry       Date:  2010-02-01       Impact factor: 3.238

3.  Urinary and plasma cyclic adenosine 3',5'-monophosphate in patients with idiopathic edema.

Authors:  O Kuchel; P Hamet; J L Cuche; G Tolis; J Fraysse; J Genest
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

Review 4.  Adverse ocular reactions to drugs.

Authors:  M A Spiteri; D G James
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

5.  A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.

Authors:  Abdulkader Alam; Zoya Voronovich; Joseph A Carley
Journal:  Prim Care Companion CNS Disord       Date:  2013-10-10

Review 6.  Idiopathic intracranial hypertension.

Authors:  Devin K Binder; Jonathan C Horton; Michael T Lawton; Michael W McDermott
Journal:  Neurosurgery       Date:  2004-03       Impact factor: 4.654

  6 in total
  1 in total

1.  Fluvoxamine-induced intracranial hypertension in a 10-year-old boy.

Authors:  Hemalini Samant; Preetam Samant
Journal:  Indian J Ophthalmol       Date:  2018-05       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.